Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$14.08 - $27.63 $1.76 Million - $3.46 Million
-125,183 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$26.55 - $40.57 $40,249 - $61,504
1,516 Added 1.23%
125,183 $3.32 Million
Q3 2021

Nov 15, 2021

SELL
$39.27 - $72.94 $573,302 - $1.06 Million
-14,599 Reduced 10.56%
123,667 $5.08 Million
Q2 2021

Aug 16, 2021

BUY
$31.29 - $56.64 $224,098 - $405,655
7,162 Added 5.46%
138,266 $7.83 Million
Q1 2021

May 17, 2021

SELL
$39.71 - $90.58 $956,931 - $2.18 Million
-24,098 Reduced 15.53%
131,104 $5.51 Million
Q4 2020

Feb 12, 2021

SELL
$27.07 - $84.35 $758,988 - $2.37 Million
-28,038 Reduced 15.3%
155,202 $10.9 Million
Q3 2020

Nov 12, 2020

BUY
$28.06 - $37.16 $3.17 Million - $4.2 Million
112,935 Added 160.64%
183,240 $5.14 Million
Q2 2020

Aug 14, 2020

BUY
$18.5 - $34.34 $291,708 - $541,473
15,768 Added 28.91%
70,305 $2.08 Million
Q1 2020

May 12, 2020

SELL
$14.88 - $32.78 $12,023 - $26,486
-808 Reduced 1.46%
54,537 $1.08 Million
Q4 2019

Feb 14, 2020

BUY
$19.49 - $32.63 $6,392 - $10,702
328 Added 0.6%
55,345 $1.64 Million
Q3 2019

Nov 15, 2019

BUY
$22.49 - $26.81 $94,930 - $113,165
4,221 Added 8.31%
55,017 $1.25 Million
Q2 2019

Aug 14, 2019

SELL
$20.48 - $27.76 $31,375 - $42,528
-1,532 Reduced 2.93%
50,796 $1.26 Million
Q1 2019

May 14, 2019

SELL
$19.43 - $26.41 $74,319 - $101,018
-3,825 Reduced 6.81%
52,328 $1.28 Million
Q4 2018

Feb 13, 2019

SELL
$18.19 - $31.79 $362,053 - $632,748
-19,904 Reduced 26.17%
56,153 $1.28 Million
Q3 2018

Nov 13, 2018

SELL
$27.65 - $38.39 $41,419 - $57,508
-1,498 Reduced 1.93%
76,057 $2.42 Million
Q2 2018

Aug 15, 2018

BUY
$31.4 - $41.01 $205,638 - $268,574
6,549 Added 9.22%
77,555 $2.78 Million
Q1 2018

May 14, 2018

SELL
$29.84 - $44.08 $1.05 Million - $1.55 Million
-35,195 Reduced 33.14%
71,006 $2.35 Million
Q4 2017

Feb 12, 2018

SELL
$21.89 - $31.34 $2.97 Million - $4.25 Million
-135,518 Reduced 56.06%
106,201 $3.26 Million
Q3 2017

Nov 14, 2017

BUY
$15.81 - $24.01 $3.82 Million - $5.8 Million
241,719
241,719 $5.8 Million

Others Institutions Holding EDIT

About Editas Medicine, Inc.


  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $85.9M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Granahan Investment Management, LLC Portfolio

Follow Granahan Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granahan Investment Management, LLC with notifications on news.